Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Period, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of re-Treatment of Prucalopride on Efficacy and Safety in Subjects With Chronic Constipation.

NCT00598338 is registered in ClinicalTrials.gov with Movetis as lead sponsor.

NCT NCT00598338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00598338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Period, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of re-Treatment of Prucalopride on Efficacy and Safety in Subjects With Chronic Constipation.
Lead sponsor
Movetis
Phase
Phase 3
Overall status
Completed
Start date
April 30, 1999
Completion date
February 29, 2000
Enrollment
516 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

constipation